JPS6472055A - Stationary phase of immune affinity chromatography - Google Patents

Stationary phase of immune affinity chromatography

Info

Publication number
JPS6472055A
JPS6472055A JP63201289A JP20128988A JPS6472055A JP S6472055 A JPS6472055 A JP S6472055A JP 63201289 A JP63201289 A JP 63201289A JP 20128988 A JP20128988 A JP 20128988A JP S6472055 A JPS6472055 A JP S6472055A
Authority
JP
Japan
Prior art keywords
stationary phase
holding body
bonding
immuno
glycol cleavage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63201289A
Other languages
English (en)
Inventor
Meiyaason Jiyoeru
Daburiyuu Imu Karubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hewlett Packard Japan Inc
Original Assignee
Yokogawa Hewlett Packard Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yokogawa Hewlett Packard Ltd filed Critical Yokogawa Hewlett Packard Ltd
Publication of JPS6472055A publication Critical patent/JPS6472055A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
JP63201289A 1987-08-14 1988-08-12 Stationary phase of immune affinity chromatography Pending JPS6472055A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8554387A 1987-08-14 1987-08-14

Publications (1)

Publication Number Publication Date
JPS6472055A true JPS6472055A (en) 1989-03-16

Family

ID=22192308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63201289A Pending JPS6472055A (en) 1987-08-14 1988-08-12 Stationary phase of immune affinity chromatography

Country Status (2)

Country Link
EP (1) EP0303406A3 (ja)
JP (1) JPS6472055A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015040817A (ja) * 2013-08-23 2015-03-02 住友ベークライト株式会社 糖タンパク質試料の調製方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2968039B2 (ja) * 1990-11-29 1999-10-25 株式会社京都第一科学 化学発光免疫測定法
JPH06507242A (ja) * 1991-05-07 1994-08-11 オックスフォード・グリコシステムズ・リミテッド オリゴ糖の配列決定
GB9310468D0 (en) * 1993-05-20 1993-07-07 Oxford Glycosystems Ltd Sugar complexes
US6802966B2 (en) 2001-08-14 2004-10-12 W. R. Grace & Co. Conn. Solid compositions for selective adsorption from complex mixtures
US6987079B2 (en) 2001-08-14 2006-01-17 W.R. Grace & Co.-Conn. Supported catalyst systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1083508A (fr) * 1975-11-13 1980-08-12 Jacques Grange Supports porteurs de chaines laterales, procedes d'obtention de ces supports, procedes de fixation de composes organiques comportant un residu glucidique sur lesdits supports, produits et reactifs resultant de ladite fixation chimique
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015040817A (ja) * 2013-08-23 2015-03-02 住友ベークライト株式会社 糖タンパク質試料の調製方法

Also Published As

Publication number Publication date
EP0303406A3 (en) 1991-07-03
EP0303406A2 (en) 1989-02-15

Similar Documents

Publication Publication Date Title
ES2112865T3 (es) Anticuerpos igg purificados.
ES2106173T3 (es) Virus vegetales modificados como vectores.
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
EP0397129A3 (en) Process for preparing an improved western blot immunoassay
JPS6472055A (en) Stationary phase of immune affinity chromatography
ATE164838T1 (de) Neue propoxyphenderivate sowie deren protein-und polypeptidlabels und-konjugate
DE3166968D1 (en) A method for the recovery of a peptide-containing compound, and an apparatus for the realization of the method
NO180558C (no) Ligandholdig medium for kromatografisk adsorpsjon, fremgangsmåte for fremstilling av mediet, samt anvendelse av mediet
DE3778446D1 (de) Kontaktlinse.
EP0635016A4 (en) BENZODIAZEPINE DERIVATIVES AND PROTEIN AND POLYPEPTIDE CONJUGATES OF SUCH DERIVATIVES.
DK0383599T3 (da) Protein-anticancermiddel
Hassoux et al. Affinity chromatography of mouse alpha-fetoprotein (AFP) on oestradiol-sepharose adsorbents—isolation and properties
AU557485B2 (en) Chromatographic-based rapid tests
Svehag et al. Ultrastructure of papain and pepsin digestion fragments of human IgM globulins
EP0303980A3 (en) Carrier coated with antigen or antibody
ATE197709T1 (de) Methadonderivate und protein- und polypeptid- methadonkonjugate und markierte verbindungen
DK329789A (da) Monoklonalt antistof
ES2061664T3 (es) Anticuerpos monoclonales que reconocen a alfa-hanp y correspondientes hibridomas, su preparacion y uso.
FI882019A0 (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
SE8104876L (sv) Immobiliserad, biologiskt aktiv substans, samt kolonn och sett for immunologiska sammanhang
King Jr et al. Total nondialyzable solids in human urine. X. Isolation and characterization of nonultrafiltrable material with blood-group substance activity
SE7807588L (sv) Hogtrycksvetskekromatografi (hplc) och dess tillempning vid separation av enzymer och antigener
EP0102008A3 (de) Carcinoembryonales Antigen, Verfahren zu seiner Isolierung und seine Verwendung
ATE201046T1 (de) Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind
IT9019132A1 (it) Assorbenti tiofilici